Search Results for "BIAL Pharmaceuticals"

03:03 EDT 3rd September 2014 | BioPortfolio

Original Source: Bial and Eisai

Founded in 1924, Bial is an international pharmaceutical group with products available in over 30 countries throughout four continents. BIAL is the largest Portuguese pharmaceutical company and is based in S. Mamede do Coronado, Portugal.

Matching Channels

None

Matching News

Bial - Portela & Ca, S.A. - Product Pipeline Review - 2014

Bial - Portela & Ca, S.A. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Bial - Portela & Ca, S.A. - Product Pipeline Review - 2014’, provides an overview of the Bial...

moksha8 to commercialize BIAL’s eslicarbazepine in Brazil And Mexico

Portuguese drugmaker BIAL and Brazil-based moksha8 have entered an exclusive license for the commercialization of eslicarbazepine acetate (Zebinix/Exalief) in Brazil and Mexico for the treatment of ep...

BIAL, moksha8 partner to commercialize Eslicarbazepine Acetate in Brazil and Mexico

BIAL, a research based international pharmaceutical company, and moksha8, a leading specialty pharmaceutical company in Latin America, have announced an exclusive license for the commercialization of ...

Bial-Portela, moksha8 deal

Bial - Portela & Ca, S.A. - Product Pipeline Review - 2014

Recently added to the BioPortfolio report store, Bial - Portela & Ca, S.A. - Product Pipeline Review - 2014 is a new report from Global Markets Direct published on 2014-07-21. This 36-page report...

Partial Seizure Global Clinical Trials Review, H2, 2014

Recently added to the BioPortfolio report store, Partial Seizure Global Clinical Trials Review, H2, 2014 is a new report from GlobalData published on 2014-07-13. This 181-page report is available in ...

Seizures Global Clinical Trials Review, H2, 2014

Recently added to the BioPortfolio report store, Seizures Global Clinical Trials Review, H2, 2014 is a new report from GlobalData published on 2014-07-27. This 112-page report is available in PDF fro...

BIAL And moksha8 Announce Exclusive License For The Commercialization Of Eslicarbazepine Acetate (Zebinix® / Exalief®) In Brazil And Mexico

WAYNE, Pa. and PORTO, Portugal, July 15, 2014 /PRNewswire/ -- BIAL, a research based international pharmaceutical company, and moksha8, a leading specialty pharmaceutical company in Lat...

Matching PubMed Articles

None

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement